Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-11 5:01 pm Purchase | 2022-08-01 | 13D | Vera Therapeutics, Inc. VERA | Carlyle Group Inc. CG | 2,970,156 11.100% | 2,970,156 (New Position) | Filing History |
| 2022-08-11 5:00 pm Purchase | 2022-08-01 | 13D | Adicet Bio, Inc. ACET | Carlyle Group Inc. CG | 134,560 5.400% | 134,560 (New Position) | Filing History |
| 2022-08-11 4:58 pm Purchase | 2022-08-01 | 13D | NuCana plc NCNA | Carlyle Group Inc. CG | 671 6.400% | 671 (New Position) | Filing History |
| 2022-08-11 4:56 pm Purchase | 2022-08-01 | 13D | Soleno Therapeutics, Inc. SLNO | Carlyle Group Inc. CG | 1,224,571 15.300% | 1,224,571 (New Position) | Filing History |
| 2022-08-11 4:55 pm Purchase | 2022-08-01 | 13D | eFFECTOR Therapeutics, Inc. EFTR | Carlyle Group Inc. CG | 193,196 11.700% | 193,196 (New Position) | Filing History |
| 2022-08-11 4:52 pm Purchase | 2022-08-01 | 13D | Reneo Pharmaceuticals, Inc. RPHM | Carlyle Group Inc. CG | 208,796 8.500% | 208,796 (New Position) | Filing History |
| 2022-08-11 4:50 pm Purchase | 2022-08-01 | 13D | Spruce Biosciences, Inc. SPRB | Carlyle Group Inc. CG | 24,034 7.700% | 24,034 (New Position) | Filing History |
| 2022-08-11 4:47 pm Purchase | 2022-08-01 | 13D | Jasper Therapeutics, Inc. JSPR | Carlyle Group Inc. CG | 562,856 15.400% | 562,856 (New Position) | Filing History |
| 2022-07-27 4:31 pm Purchase | 2021-12-31 | 13D | Vistance Networks, Inc. VISN | Carlyle Group Inc. CG | 39,468,542 16.000% | 3,104,942 (+8.54%) | Filing History |
| 2022-06-14 4:41 pm Sale | 2022-06-09 | 13D | The Carlyle Group Inc. CG | Carlyle Group Management L.L.C. | 152,131,004 42.100% | -3,724,382 (-2.39%) | Filing History |
| 2022-06-06 5:17 pm Purchase | 2022-05-27 | 13D | QuidelOrtho Corporation QDEL | Carlyle Group Inc. CG | 12,460,183 18.600% | 12,460,183 (New Position) | Filing History |
| 2022-02-14 2:33 pm Sale | 2021-12-31 | 13G | The Carlyle Group Inc. CG | Vulcan Value Partners LLC | 16,609,123 4.660% | -8,810,166 (-34.66%) | Filing History |
| 2022-02-11 4:31 pm Sale | 2021-12-31 | 13G | CORESITE REALTY CORPORATION CO | Carlyle Group Inc. CG | 0 0.000% | -5,875,218 (Position Closed) | Filing History |
| 2022-02-11 4:22 pm Purchase | 2021-12-31 | 13G | Ortho Clinical Diagnostics Holdings plc OCDX | Carlyle Group Inc. CG | 118,106,000 49.900% | 118,106,000 (New Position) | Filing History |
| 2022-02-11 4:21 pm Purchase | 2021-12-31 | 13G | ATOTECH LTD COM JEY ATC | Carlyle Group Inc. CG | 153,672,703 78.900% | 153,672,703 (New Position) | Filing History |
| 2022-02-11 4:20 pm Unchanged | 2021-12-31 | 13G | 1Life Healthcare, Inc. ONEM | Carlyle Group Inc. CG | 13,612,681 7.100% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:20 pm Sale | 2021-12-31 | 13G | ZoomInfo Technologies Inc. GTM | Carlyle Group Inc. CG | 44,241,982 11.800% | -48,975,337 (-52.54%) | Filing History |
| 2022-02-11 4:17 pm Sale | 2021-12-31 | 13G | The Carlyle Group Inc. CG | Rubenstein David M. | 31,249,644 8.800% | -11,000,000 (-26.04%) | Filing History |
| 2022-02-11 4:16 pm Purchase | 2021-12-31 | 13G | Black Stone Minerals, L.P. BSM | Carlyle Group Inc. CG | 14,711,219 6.600% | 14,711,219 (New Position) | Filing History |
| 2022-02-11 4:15 pm Sale | 2021-12-31 | 13G | Vitru Limited VTRU | Carlyle Group Inc. CG | 4,164,314 17.700% | -2,082,157 (-33.33%) | Filing History |